These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25943468)

  • 21. ARBs for cardiovascular and renal protection in high-risk patients.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(4):224. PubMed ID: 21881697
    [No Abstract]   [Full Text] [Related]  

  • 22. Telmisartan on top of antihypertensive treatment does not prevent progression of cerebral white matter lesions in the prevention regimen for effectively avoiding second strokes (PRoFESS) MRI substudy.
    Weber R; Weimar C; Blatchford J; Hermansson K; Wanke I; Möller-Hartmann C; Gizewski ER; Forsting M; Demchuk AM; Sacco RL; Saver JL; Warach S; Diener HC; Diehl A;
    Stroke; 2012 Sep; 43(9):2336-42. PubMed ID: 22738922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of telmisartan plus amlodipine in the treatment of hypertension: review of results.
    Oigman W; Neves MF; Gismondi RA
    Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1509-17. PubMed ID: 21090924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New studies on hypertension of great significance to clinical practice. Also very old persons benefit from blood pressure reduction].
    Nilsson PM
    Lakartidningen; 2008 May 7-13; 105(19):1382-4. PubMed ID: 18574975
    [No Abstract]   [Full Text] [Related]  

  • 25. [In the framework of the 72nd Annual Meeting of the DKG (German CardiologySociety) in Mannheim presented: Ontarget-the until now largest study program on cardiovascular prevention in patients with hypertension].
    MMW Fortschr Med; 2006 Jun; 148(26):50-1. PubMed ID: 16875381
    [No Abstract]   [Full Text] [Related]  

  • 26. [Study on cognition and prognosis in the elderly].
    Kohara K
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():425-30. PubMed ID: 16981574
    [No Abstract]   [Full Text] [Related]  

  • 27. Aliskiren combined with losartan in diabetes and nephropathy.
    Panesar M; Damodar A
    N Engl J Med; 2008 Sep; 359(10):1068; author reply 1069-70. PubMed ID: 18768954
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study.
    Ihm SH; Jeon HK; Cha TJ; Hong TJ; Kim SH; Lee NH; Yoon JH; Yoon N; Hwang KK; Jo SH; Youn HJ
    Drug Des Devel Ther; 2016; 10():3817-3826. PubMed ID: 27920497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).
    Papademetriou V; Farsang C; Elmfeldt D; Hofman A; Lithell H; Olofsson B; Skoog I; Trenkwalder P; Zanchetti A;
    J Am Coll Cardiol; 2004 Sep; 44(6):1175-80. PubMed ID: 15364316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lowering blood pressure in acute stroke: the SCAST trial.
    Hankey GJ
    Lancet; 2011 Feb; 377(9767):696-8. PubMed ID: 21316753
    [No Abstract]   [Full Text] [Related]  

  • 31. Current status of angiotensin receptor blockers for the treatment of cardiovascular diseases: focus on telmisartan.
    Chrysant SG; Chrysant GS; Desai A
    J Hum Hypertens; 2005 Mar; 19(3):173-83. PubMed ID: 15660122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A trial of telmisartan prevention of cardiovascular diseases (ATTEMPT-CVD): Biomarker study.
    Ogawa H; Soejima H; Matsui K; Kim-Mitsuyama S; Yasuda O; Node K; Yamamuro M; Yamamoto E; Kataoka K; Jinnouchi H; Sekigami T;
    Eur J Prev Cardiol; 2016 Jun; 23(9):913-21. PubMed ID: 26324672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapy of hypertension. Pulse pressure must also be reduced].
    MMW Fortschr Med; 2003 May; 145(18):54. PubMed ID: 12808823
    [No Abstract]   [Full Text] [Related]  

  • 34. Telmisartan/hydrochlorothiazide: a new fixed dose combination.
    Maillard M; Burnier M
    Expert Rev Cardiovasc Ther; 2005 May; 3(3):375-86. PubMed ID: 15889965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effects of telmisartan and valsartan as add-on agents for hypertensive patients with morning blood pressure insufficiently controlled by amlodipine monotherapy.
    Yoshida H; Akasaka H; Saitoh S; Shimamoto K; Miura T;
    Hypertens Res; 2014 Mar; 37(3):225-31. PubMed ID: 24108237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapy of hypertension. Lasting organ protection moves into the foreground].
    MMW Fortschr Med; 2003 Nov; 145(47):62. PubMed ID: 14738040
    [No Abstract]   [Full Text] [Related]  

  • 37. Telmisartan 80 mg/hydrochlorothiazide 25 mg provides clinically relevant blood pressure reductions across baseline blood pressures.
    Neldam S; Schumacher H; Guthrie R
    Adv Ther; 2012 Apr; 29(4):327-38. PubMed ID: 22477543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of hypertension. Pulse pressure must also be reduced].
    MMW Fortschr Med; 2004 May; 146(21):63. PubMed ID: 15373094
    [No Abstract]   [Full Text] [Related]  

  • 39. Potential effects of angiotensin II receptor blockers on glucose tolerance and adiponectin levels in hypertensive patients.
    Makita S; Abiko A; Naganuma Y; Moriai Y; Nakamura M
    Cardiovasc Drugs Ther; 2007 Aug; 21(4):317-8. PubMed ID: 17629779
    [No Abstract]   [Full Text] [Related]  

  • 40. [PPARgamma-activating properties of angiotensin receptor blockers].
    Ando H; Fujimura A
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():498-501. PubMed ID: 16895217
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.